Successful management of a patient with pseudomalabsorption of levothyroxine
- PMID: 12968832
- DOI: 10.2190/0YWR-8DRV-HHP4-UE2E
Successful management of a patient with pseudomalabsorption of levothyroxine
Abstract
Pseudomalabsorption of levothyroxine is a factitious disorder. Despite the administration of large doses of levothyroxine, patients with this disorder show hypothyroidism due to noncompliance. These patients are different from the patients with simple noncompliance in that they have a psychiatric disorder. Because their psychological identities are rooted in their being a "patient," they go to great lengths to become and stay a patient. We report a case of pseudomalabsorption of levothyroxine. A 28-year-old woman was referred to us because she was believed to have unusual malabsorption of levothyroxine. We diagnosed the patient as having this factitious disorder, and as treatment, had her visit a hospital twice a week to take medicine under the observation of nurses so that she would not lose her status as a "patient." Her serum free T4 level normalized during three years with twice weekly dosing of thyroxine after hospital discharge. Our approach could be a therapeutic choice for this intractable disorder. To our knowledge, this is the first report of successful management of a patient with pseudomal-absorption of levothyroxine.
Similar articles
-
[Pseudomalabsorption of levothyroxine: a case report].Arq Bras Endocrinol Metabol. 2005 Apr;49(2):308-13. doi: 10.1590/s0004-27302005000200020. Epub 2005 Sep 12. Arq Bras Endocrinol Metabol. 2005. PMID: 16184262 Portuguese.
-
[L-thyroxine pseudomalabsorption: a factitious disease].Presse Med. 2007 Oct;36(10 Pt 1):1390-4. doi: 10.1016/j.lpm.2006.09.024. Epub 2007 Apr 18. Presse Med. 2007. PMID: 17446037 French.
-
Diagnosis and treatment of levothyroxine pseudomalabsorption.Neth J Med. 2004 Apr;62(4):114-8. Neth J Med. 2004. PMID: 15255080 Review.
-
Pseudomalabsorption of levothyroxine: a case report.Endocr J. 2000 Feb;47(1):45-50. doi: 10.1507/endocrj.47.45. Endocr J. 2000. PMID: 10811292
-
The influence of lactose intolerance and other gastro-intestinal tract disorders on L-thyroxine absorption.Endokrynol Pol. 2012;63(4):318-23. Endokrynol Pol. 2012. PMID: 22933169 Review.
Cited by
-
Rapid Levothyroxine Absorption Testing: A Case Series of Nonadherent Patients.Int J Endocrinol Metab. 2015 Oct 13;13(4):e31051. doi: 10.5812/ijem.31051. eCollection 2015 Oct. Int J Endocrinol Metab. 2015. PMID: 26633982 Free PMC article.
-
Pseudomalabsorption of Levothyroxine: A Challenge for the Endocrinologist in the Treatment of Hypothyroidism.Eur Thyroid J. 2017 Feb;6(1):52-56. doi: 10.1159/000452489. Epub 2016 Nov 24. Eur Thyroid J. 2017. PMID: 28611949 Free PMC article.
-
Adherence Labeling: Understanding the Origins, Limitations, and Ethical Challenges of "Diagnosing" Nonadherence.Ann Fam Med. 2025 May 27;23(3):255-261. doi: 10.1370/afm.240358. Ann Fam Med. 2025. PMID: 40425480 Free PMC article.
-
Validity of the Rapid Thyroxine Absorption Test for the Differentiation Between Levothyroxine Non-compliance and Malabsorption in Thyroid-Stimulating Hormone Refractory Hypothyroidism.Cureus. 2023 Apr 18;15(4):e37776. doi: 10.7759/cureus.37776. eCollection 2023 Apr. Cureus. 2023. PMID: 37214056 Free PMC article.
-
Levothyroxine: Conventional and Novel Drug Delivery Formulations.Endocr Rev. 2023 May 8;44(3):393-416. doi: 10.1210/endrev/bnac030. Endocr Rev. 2023. PMID: 36412275 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical